CytomX Therapeutics (CTMX) Shares Issued (2016 - 2025)
Historic Shares Issued for CytomX Therapeutics (CTMX) over the last 11 years, with Q2 2025 value amounting to $93.4 million.
- CytomX Therapeutics' Shares Issued rose 189985.01% to $93.4 million in Q2 2025 from the same period last year, while for Sep 2025 it was $95.4 million, marking a year-over-year increase of 187047.28%. This contributed to the annual value of $6.9 million for FY2024, which is 7674.34% down from last year.
- Latest data reveals that CytomX Therapeutics reported Shares Issued of $93.4 million as of Q2 2025, which was up 189985.01% from $2.1 million recorded in Q4 2024.
- Over the past 5 years, CytomX Therapeutics' Shares Issued peaked at $107.7 million during Q1 2021, and registered a low of $7000.0 during Q1 2022.
- For the 5-year period, CytomX Therapeutics' Shares Issued averaged around $23.8 million, with its median value being $1.3 million (2022).
- In the last 5 years, CytomX Therapeutics' Shares Issued skyrocketed by 489360.22% in 2021 and then crashed by 9999.35% in 2022.
- Quarter analysis of 5 years shows CytomX Therapeutics' Shares Issued stood at $107.7 million in 2021, then crashed by 99.82% to $190000.0 in 2022, then soared by 15348.42% to $29.4 million in 2023, then tumbled by 92.99% to $2.1 million in 2024, then skyrocketed by 4439.28% to $93.4 million in 2025.
- Its Shares Issued stands at $93.4 million for Q2 2025, versus $2.1 million for Q4 2024 and $4.7 million for Q2 2024.